Case Studies / Portfolio, Licensing and Development
Assessing strategy across 4 immunology areas to inform franchise and acquisition approach
Challenge
A Global Executive Director for Immunology Strategy at a top 10 pharmaceutical company sought to examine unmet needs, reimbursement landscape (US, EU, Japan) and emerging competitors across 4 immunology therapeutic areas
The client needed to understand relative degrees of opportunity and hurdles to inform overall franchise strategy around resource allocation, development thresholds and a potential acquisition
Approach
Created a strategic framework to compare degree of opportunity by patient subpopulation and therapeutic area
Benchmarked clinical outcomes for promising late-stage candidates and interviewed R&D experts to inform development hurdles
Guided market research with thought leaders, community physicians and payers to probe unmet needs, shifting treatment algorithms and reimbursement landscape
Led multiple cross-functional workshops with R&D, brand, regulatory and market access teams to pressure-test assumptions
Results
Our client used output from our analyses to inform minimal and ideal development hurdles (TPPs) and trial design
Opus Strategy’s work played an important role in informing a subsequent major immunology acquisition (~$600 MM)
